Revatio
Revatio contains sildenafil, a phosphodiesterase-5 (PDE5) inhibitor. It works by relaxing the blood vessels in the lungs, which lowers blood pressure in the pulmonary arteries and reduces the workload on the heart, ultimately improving exercise tolerance.
Dosage by Body Weight
Adults: The recommended dose is 5 mg or 20 mg three times daily, taken approximately 4 to 6 hours apart. Pediatrics: Dosing is typically weight-based and administered as oral suspension.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy in infants weighing less than 5 kg or under 1 year of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- 10 mg
- Frequency
- Three times daily
- Tracking Notes
- Administered via oral suspension. Pediatric dosing should be closely monitored by a specialist.
- Body Weight
- 8-10 kg
- Dose
- 10 mg
- Frequency
- Three times daily
- Tracking Notes
- Ensure precise measurement using an oral dosing syringe.
- Body Weight
- 11-15 kg
- Dose
- 10 mg
- Frequency
- Three times daily
- Tracking Notes
- Shake oral suspension well before use. Store reconstituted suspension in a refrigerator.
- Body Weight
- 16-20 kg
- Dose
- 10 mg
- Frequency
- Three times daily
- Tracking Notes
- Pediatric patients weighing more than 20 kg are typically transitioned to the standard 20 mg dose three times daily.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and efficacy in infants weighing less than 5 kg or under 1 year of age have not been established. |
| 5-7 kg | 10 mg | Three times daily | Administered via oral suspension. Pediatric dosing should be closely monitored by a specialist. |
| 8-10 kg | 10 mg | Three times daily | Ensure precise measurement using an oral dosing syringe. |
| 11-15 kg | 10 mg | Three times daily | Shake oral suspension well before use. Store reconstituted suspension in a refrigerator. |
| 16-20 kg | 10 mg | Three times daily | Pediatric patients weighing more than 20 kg are typically transitioned to the standard 20 mg dose three times daily. |
Formulation
TabletOral SuspensionInjection
Purpose
Treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adults and pediatric patients to improve exercise ability and delay clinical worsening.
Generic Name
SildenafilScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.